Skip to main content

Epoprostenol Sodium Injection Shortage

Last Updated: January 31, 2025
Status: Discontinued

To Be Discontinued:

Flolan, Injection, .5 mg (GlaxoSmithKline)

NDC Code: 0173-0517-00
Status: To Be Discontinued
Date of update: January 31, 2025
Update type: New
Related Information: The anticipated date that GSK will cease distribution of the product is approximately November 30, 2025.
Therapeutic category: Cardiovascular
Date discontinued: January 31, 2025
Initial posting date: January 31, 2025
Contact info: 888-825-5249

Flolan, Injection, 1 mL/1 mL (GlaxoSmithKline)

NDC Code: 0173-0857-02
Status: To Be Discontinued
Date of update: January 31, 2025
Update type: New
Related Information: The anticipated date that GSK will cease distribution of the product is approximately November 30, 2025.
Therapeutic category: Cardiovascular
Date discontinued: January 31, 2025
Initial posting date: January 31, 2025
Contact info: 888-825-5249

Flolan, Injection, 1.5 mg (GlaxoSmithKline)

NDC Code: 0173-0519-00
Status: To Be Discontinued
Date of update: January 31, 2025
Update type: New
Related Information: The anticipated date that GSK will cease distribution of the product is approximately November 30, 2025.
Therapeutic category: Cardiovascular
Date discontinued: January 31, 2025
Initial posting date: January 31, 2025
Contact info: 888-825-5249

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer